Your Strategic Partner for Market Access & Success in France:
Medical, Commercial & Regulatory Expertise
Access Pharma Consulting (APC) helps international pharma, biotech and medical device companies enter and succeed in the French market.
From regulatory approvals and reimbursement to KOL engagement and hospital access, APC delivers strategies that combine compliance with commercial success.
About APC
About Us
Access Pharma Consulting (APC) is a high-level consultancy dedicated to helping pharmaceutical, biotech, and medical device companies navigate the regulatory and commercial complexities of the French healthcare system.
With more than a decade of leadership in pharmaceutical environments, APC combines medical insight, regulatory expertise, and market access strategy to accelerate successful entry and sustainable growth in France.
In addition to broad expertise in specialty pharma and hospital markets, APC provides cutting-edge guidance for medical cannabis companies entering the French market; from regulatory approvals and ANSM/HAS submissions to market access, pricing models, and stakeholder engagement.
We partner with your teams to craft tailored strategies adapted to your product, therapeutic area, and stakeholder landscape, from market positioning to execution.
Our senior-level expertise ensures your go-to-market plans are both locally grounded and globally aligned, driving measurable results in one of Europe’s most complex healthcare markets.
More than navigating the French healthcare system, we unlock it for your success.
Strategic Services to Accelerate Your Product Success in France
Tailored Expertise Across the Product Journey
At APC, we design and deliver high-level strategic interventions tailored to your product, development stage, and market objectives.
Whether you're exploring the French market, preparing a launch, or refining your access strategy, we align medical, regulatory, and commercial dimensions to unlock success.
Why Choose Access Pharma Consulting?
Led by Dr. Dounia Farajallah, PharmD & ESSEC-trained strategist, combining medical insight with executive-level business acumen.
12+ years of senior leadership in the pharmaceutical industry, including the successful launch and management of a French subsidiary for an international pharma group.
Proven experience in securing regulatory approvals, market access, and pricing strategies in complex therapeutic areas.
Deep mastery of the French healthcare system, including ANSM, HAS, reimbursement pathways, and hospital tenders.
Trusted by global innovators in pharma, biotech, and medical cannabis for strategic market access in France.
![24093 [Converted]-01.jpg](https://static.wixstatic.com/media/46f5a9_49032bdb9c9748b2a8891fc2bb42dfce~mv2.jpg/v1/fill/w_348,h_232,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/46f5a9_49032bdb9c9748b2a8891fc2bb42dfce~mv2.jpg)
Core Service Areas:
Regulatory
Affairs
Providing end-to-end support for AMM, ATU, and early access programs in France, including regulatory writing, dossier preparation, pre-submission advice, ANSM interactions, and timeline optimization.
Market Access Strategy & Stakeholder Mapping
Conducting tailored analyses of the French healthcare and reimbursement landscape, aligned with your product development stage, including market segmentation, competitive positioning, and stakeholder mapping.
Medical Affairs & Stakeholder Strategy
Engaging with key opinion leaders (KOLs), medical boards, and clinical stakeholders across France. We refine your scientific positioning and align your medical strategy with local institutional expectations
Tailored Strategic
Sessions
Delivering executive workshops and targeted trainings for global and local teams, accelerating understanding of the French healthcare system, HAS, CEPS, and ANSM processes.
Compliance & Post-Launch Support
Reviewing promotional and scientific materials to ensure compliance with French regulations. We develop ANSM-compliant content, support medical information flows, and oversee post-launch activities.
Contact Us
Let’s Accelerate Your Strategy in France
Access Pharma Consulting (APC) supports pharmaceutical, biotech, and medical cannabis companies entering or growing in the French market through strategic guidance, regulatory expertise, and market access execution.
Whether you’re defining your entry strategy, preparing regulatory submissions, or engaging with key stakeholders, APC provides the clarity and senior-level support you need to move forward with confidence.
Let’s make your success in the French market a reality. Contact us to explore how we can support you.
Follow Us